Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, will deliver a poster presentation at the 2013 San Antonio Breast Cancer Symposium (SABCS) taking place December 10-14.
The abstract (#P1-12-01) is entitled, “Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Metastatic Breast Cancer,” and will be presented during Poster Session 1 on Wednesday, December 11, 2013, from 5:00 pm -7:00 pm in Exhibit Hall A of the San Antonio Convention Center. The poster will highlight findings from a study conducted by CCO that sought to determine whether expert recommendations on the treatment of metastatic breast cancer (MBC), delivered via interactive, online decision support tools, would change or confirm the treatment decisions of community practitioners.
An analysis of nearly 2000 patient cases entered into CCO’s online interactive MBC decision support tools indicated that community practitioners are recommending newly approved agents substantially less frequently than expert oncologists. After using the online tools, 87% of community practitioners indicated that the expert recommendations either confirmed or changed their intended clinical approach. These data suggest that online tools that provide customized, patient-specific expert advice may increase the number of clinicians who make optimal treatment decisions for patients with MBC.
“CCO is committed to helping clinicians make optimal treatment decisions by combining expert educational content and the latest clinical management guidelines with innovative technological platforms,” said Trish Bates Doolin, General Manager, CCO Oncology. “We are pleased to share the successful impact our decision support tools can have on clinical practice with our colleagues at SABCS.”
The 2013 MBC Interactive Decision Support Tool is available at http://clinicaloptions.com/MBCInsight and is part of the CME-certified educational program, “Expert Guidance on Selecting Treatment and Management Approaches in Metastatic Breast Cancer,” that is supported by unrestricted grants from Genentech and Novartis.
About Clinical Care Options
Clinical Care Options is the leader in the development of innovative educational technology platform that integrates all levels of medical education and information with personalization of the clinician’s experience and the integration of moderated social media. CCO has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals. For more information, visit clinicaloptions.com.
inPractice Resources (a wholly owned subsidiary of CCO) delivers specialized clinical reference and education content specifically designed to meet the information needs of specialist physicians, nurses, and other care providers. Available for specialties including hepatology, HIV, oncology, and rheumatology, inPractice is available digitally, via online and mobile devices, or can be integrated with other workflow tools. For more information, visit inPractice.com.